Biotech · Private company
PureTech
Track this companyFree. Adds PureTech to your Dealase workspace and tells you when its record changes.
Clinical trials72 recruiting or active
Pipeline programs15From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline15
- DeupirfenidonePhase 3 · Idiopathic Pulmonary Fibrosis (IPF)ClinicalTrials.gov · fetched Nov 12, 2026
- Pirfenidone (PFD)Phase 3 · Idiopathic Pulmonary Fibrosis (IPF)ClinicalTrials.gov · fetched Nov 12, 2026
- DeupirfenidonePhase 2 · Idiopathic Pulmonary FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- Gemcitabine/nab-paclitaxelPhase 2 · Metastatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- LYT-100Phase 2 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
- LYT-100 BCRLPhase 2 · Breast Cancer Related LymphoedemaClinicalTrials.gov · fetched Nov 12, 2026
- LYT-200Phase 2 · Metastatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- PirfenidonePhase 2 · Idiopathic Pulmonary FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- TislelizumabPhase 2 · Metastatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- AzacitidinePhase 1 · AML, Adult RecurrentClinicalTrials.gov · fetched Nov 12, 2026
- DecitabinePhase 1 · AML, Adult RecurrentClinicalTrials.gov · fetched Nov 12, 2026
- DeupirfenidonePhase 1 · Pharmacokinetic AnalysisClinicalTrials.gov · fetched Nov 12, 2026
- LYT-200Phase 1 · AML, Adult RecurrentClinicalTrials.gov · fetched Nov 12, 2026
- Pirfenidone (PFD)Phase 1 · Pharmacokinetic AnalysisClinicalTrials.gov · fetched Nov 12, 2026
- VenetoclaxPhase 1 · AML, Adult RecurrentClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)PHASE3 · RECRUITING · started Jun 26, 2026ClinicalTrials.gov NCT07284602 · fetched Nov 12, 2026
- A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS)PHASE1 · COMPLETED · started Dec 12, 2022ClinicalTrials.gov NCT05829226 · fetched Nov 12, 2026
- LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)PHASE2 · ACTIVE_NOT_RECRUITING · started Jul 22, 2022ClinicalTrials.gov NCT05321420 · fetched Nov 12, 2026
- PK of Deupirfenidone Versus Pirfenidone in Older Healthy SubjectsPHASE1 · COMPLETED · started Jul 12, 2021ClinicalTrials.gov NCT07456800 · fetched Nov 12, 2026
- LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid TumorsPHASE1_PHASE2 · COMPLETED · started Dec 15, 2020ClinicalTrials.gov NCT04666688 · fetched Nov 12, 2026
- LYT-100 in Post-acute COVID-19 Respiratory DiseasePHASE2 · TERMINATED · started Dec 11, 2020ClinicalTrials.gov NCT04652518 · fetched Nov 12, 2026
- LYT-100 in Patients With BCRLPHASE2 · TERMINATED · started Mar 1, 2020ClinicalTrials.gov NCT04243837 · fetched Nov 12, 2026